Stephen M. Ansell, MD, PhD, on Hodgkin Lymphoma: Beyond Checkpoint Inhibitors

Pan Pacific Lymphoma Conference 2018

Stephen M. Ansell, MD, PhD, of the Mayo Clinic, discusses the efficacy of PD-1 blockade in Hodgkin lymphoma, new findings related to PD-1 therapy, current combination approaches, and future treatments.

Aug

Today In Oncology

FDA Approves Nivolumab for Certain Patients With Previously Treated Small Cell Lung Cancer

BRCA Testing in Medically Underserved Women in Southeastern United States

FDA Accepts Biologics License Application, Grants Priority Review for Tagraxofusp in Rare Hematologic Malignancy

Functional and Social Independence in Survivors of Pediatric CNS Tumors

Bendamustine Followed by Obinutuzumab Plus Venetoclax in Treatment-Naive and Relapsed/Refractory CLL

;